196 related articles for article (PubMed ID: 31424086)
1. Cytometry by time of flight identifies distinct signatures in patients with systemic sclerosis, systemic lupus erythematosus and Sjögrens syndrome.
van der Kroef M; van den Hoogen LL; Mertens JS; Blokland SLM; Haskett S; Devaprasad A; Carvalheiro T; Chouri E; Vazirpanah N; Cossu M; Wichers CGK; Silva-Cardoso SC; Affandi AJ; Bekker CPJ; Lopes AP; Hillen MR; Bonte-Mineur F; Kok MR; Beretta L; Rossato M; Mingueneau M; van Roon JAG; Radstake TRDJ
Eur J Immunol; 2020 Jan; 50(1):119-129. PubMed ID: 31424086
[TBL] [Abstract][Full Text] [Related]
2. Increased antibody levels to stage-specific Epstein-Barr virus antigens in systemic autoimmune diseases reveal a common pathology.
Sternbæk L; Draborg AH; Østerlund MT; Iversen LV; Troelsen L; Theander E; Nielsen CT; Jacobsen S; Houen G
Scand J Clin Lab Invest; 2019; 79(1-2):7-16. PubMed ID: 30727744
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic value of screening enzyme immunoassays compared to indirect immunofluorescence for anti-nuclear antibodies in patients with systemic rheumatic diseases: A systematic review and meta-analysis.
Jeong S; Yang D; Lee W; Kim GT; Kim HS; Ahn HS; Kim HJ
Semin Arthritis Rheum; 2018 Oct; 48(2):334-342. PubMed ID: 29609799
[TBL] [Abstract][Full Text] [Related]
4. Autoantibodies associated with systemic sclerosis in three autoimmune diseases imprinted by type I interferon gene dysregulation: a comparison across SLE, primary Sjögren's syndrome and systemic sclerosis.
Andraos R; Ahmad A; Eriksson P; Dahlström Ö; Wirestam L; Dahle C; Hesselstrand R; Bengtsson AA; Jönsen A; Andréasson K; Sjöwall C
Lupus Sci Med; 2022 Dec; 9(1):. PubMed ID: 36581379
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of usefulness of Polycheck method in the detection autoantibodies in patients with systemic lupus erythematosus, Sjögren's syndrome and systemic sclerosis].
Dryglewskal M; Majdan M; Koszarny A; Grytal A; Grzywnowicz M
Wiad Lek; 2015; 68(3):252-8. PubMed ID: 26753209
[TBL] [Abstract][Full Text] [Related]
6. Deep Phenotyping of CD11c
Rincon-Arevalo H; Wiedemann A; Stefanski AL; Lettau M; Szelinski F; Fuchs S; Frei AP; Steinberg M; Kam-Thong T; Hatje K; Keller B; Warnatz K; Radbruch A; Lino AC; Schrezenmeier E; Dörner T
Front Immunol; 2021; 12():635615. PubMed ID: 33777025
[TBL] [Abstract][Full Text] [Related]
7. Comparative single-cell multiplex immunophenotyping of therapy-naive patients with rheumatoid arthritis, systemic sclerosis, and systemic lupus erythematosus shed light on disease-specific composition of the peripheral immune system.
Balog JÁ; Zvara Á; Bukovinszki V; Puskás LG; Balog A; Szebeni GJ
Front Immunol; 2024; 15():1376933. PubMed ID: 38726007
[TBL] [Abstract][Full Text] [Related]
8. Detection of circulating soluble CD28 in patients with systemic lupus erythematosus, primary Sjögren's syndrome and systemic sclerosis.
Hebbar M; Jeannin P; Magistrelli G; Hatron PY; Hachulla E; Devulder B; Bonnefoy JY; Delneste Y
Clin Exp Immunol; 2004 May; 136(2):388-92. PubMed ID: 15086406
[TBL] [Abstract][Full Text] [Related]
9. Excess Productivity Costs of Systemic Lupus Erythematosus, Systemic Sclerosis, and Sjögren's Syndrome: A General Population-Based Study.
McCormick N; Marra CA; Sadatsafavi M; Kopec JA; Aviña-Zubieta JA
Arthritis Care Res (Hoboken); 2019 Jan; 71(1):142-154. PubMed ID: 29648677
[TBL] [Abstract][Full Text] [Related]
10. A comprehensive investigation on the distribution of circulating follicular T helper cells and B cell subsets in primary Sjögren's syndrome and systemic lupus erythematosus.
Szabó K; Papp G; Szántó A; Tarr T; Zeher M
Clin Exp Immunol; 2016 Jan; 183(1):76-89. PubMed ID: 26358223
[TBL] [Abstract][Full Text] [Related]
11. Anti-hnRNP B1 (RA33) autoantibodies are associated with the clinical phenotype in Russian patients with rheumatoid arthritis and systemic sclerosis.
Maslyanskiy A; Lazareva N; Olinek P; Schierack P; Hentschel C; Cuccato J; Bogdanos DP; Lapin SV; Roggenbuck D
J Immunol Res; 2014; 2014():516593. PubMed ID: 24883333
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of Fas on group 2 and 3 innate lymphoid cells is associated with an interferon signature in systemic lupus erythematosus and Sjögren's syndrome.
Blokland SLM; van den Hoogen LL; Leijten EFA; Hartgring SAY; Fritsch R; Kruize AA; van Roon JAG; Radstake TRDJ
Rheumatology (Oxford); 2019 Oct; 58(10):1740-1745. PubMed ID: 31220315
[TBL] [Abstract][Full Text] [Related]
13. The autoimmune diseases.
Condemi JJ
JAMA; 1992 Nov; 268(20):2882-92. PubMed ID: 1433704
[No Abstract] [Full Text] [Related]
14. Rheumatoid arthritis, systemic lupus erythematosus and primary Sjögren's syndrome shared megakaryocyte expansion in peripheral blood.
Wang Y; Xie X; Zhang C; Su M; Gao S; Wang J; Lu C; Lin Q; Lin J; Matucci-Cerinic M; Furst DE; Zhang G
Ann Rheum Dis; 2022 Mar; 81(3):379-385. PubMed ID: 34462261
[TBL] [Abstract][Full Text] [Related]
15. Liver abnormalities in connective tissue diseases.
De Santis M; Crotti C; Selmi C
Best Pract Res Clin Gastroenterol; 2013 Aug; 27(4):543-51. PubMed ID: 24090941
[TBL] [Abstract][Full Text] [Related]
16. TBK1: A key regulator and potential treatment target for interferon positive Sjögren's syndrome, systemic lupus erythematosus and systemic sclerosis.
Bodewes ILA; Huijser E; van Helden-Meeuwsen CG; Tas L; Huizinga R; Dalm VASH; van Hagen PM; Groot N; Kamphuis S; van Daele PLA; Versnel MA
J Autoimmun; 2018 Jul; 91():97-102. PubMed ID: 29673738
[TBL] [Abstract][Full Text] [Related]
17. Nervous system involvement in systemic lupus erythematosus, Sjögren syndrome and scleroderma.
Hietaharju A; Jäntti V; Korpela M; Frey H
Acta Neurol Scand; 1993 Oct; 88(4):299-308. PubMed ID: 8256578
[TBL] [Abstract][Full Text] [Related]
18. Stratification of Patients With Sjögren's Syndrome and Patients With Systemic Lupus Erythematosus According to Two Shared Immune Cell Signatures, With Potential Therapeutic Implications.
Martin-Gutierrez L; Peng J; Thompson NL; Robinson GA; Naja M; Peckham H; Wu W; J'bari H; Ahwireng N; Waddington KE; Bradford CM; Varnier G; Gandhi A; Radmore R; Gupta V; Isenberg DA; Jury EC; Ciurtin C
Arthritis Rheumatol; 2021 Sep; 73(9):1626-1637. PubMed ID: 33645922
[TBL] [Abstract][Full Text] [Related]
19. Sjogren's syndrome is associated with and not secondary to systemic sclerosis.
Salliot C; Mouthon L; Ardizzone M; Sibilia J; Guillevin L; Gottenberg JE; Mariette X
Rheumatology (Oxford); 2007 Feb; 46(2):321-6. PubMed ID: 16877466
[TBL] [Abstract][Full Text] [Related]
20. [Clinical aspects, diagnosis and combined treatment of Sjögren's syndrome].
Solntsev AM; Kolesov VS; Sakharchuk VM
Vrach Delo; 1981 Jul; (7):93-6. PubMed ID: 7281627
[No Abstract] [Full Text] [Related]
[Next] [New Search]